Gemcitabine 38 mg/mL (Gemcitabine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 38 mg/mL

Gemcitabine 38 mg/mL is a lyophilized powder for solution, used in intravenous treatments. This medication is commonly associated with cancer therapies and is manufactured by Hospira, Inc. in the USA.

Strength

38 mg/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0185-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine 38 mg/mL is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells. This medication is often prescribed as part of a broader treatment plan, which may include other therapies. Patients and healthcare providers typically discuss the specific uses of Gemcitabine based on individual health conditions.

Side Effects

Common effects of Gemcitabine 38 mg/mL may include fatigue, nausea, and a decreased blood cell count. Some patients may also experience hair loss and changes in appetite. These effects can vary widely depending on the individual and the specific treatment plan. It is important to monitor for any adverse reactions and consult with a healthcare provider if concerns arise.

Precautions & Warnings

Gemcitabine 38 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Patients should be aware of potential side effects and discuss any pre-existing conditions with their healthcare provider before starting treatment. Proper disposal of unused medication is also crucial to prevent accidental exposure.

Avoid Interactions

Gemcitabine 38 mg/mL may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy and safety of Gemcitabine. Always consult with a healthcare provider for personalized advice.

Frequently Asked Questions

Gemcitabine 38 mg/mL is primarily used in the treatment of various types of cancer, often as part of a broader treatment plan.

Gemcitabine 38 mg/mL is administered intravenously after being reconstituted as a solution.

Common side effects may include fatigue, nausea, and a decreased blood cell count. Hair loss and changes in appetite are also possible.

Gemcitabine 38 mg/mL may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Gemcitabine 38 mg/mL should be stored according to the manufacturer's guidelines to maintain its potency and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.